Optiscan
Imaging company and is in the development and application of microscopic imaging technologies for medical markets.
Launch date
Employees
Market cap
CAD118m
Enterprise valuation
CAD113m (Public information from Sep 2024)
Share price
AUD0.15 OIL.AX
Company register number 077771987
Melbourne Victoria (HQ)
Financials
Estimates*
| AUD | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Revenues | - | - | 1.2m | <1m | 1.0m | 1.7m | - |
| % growth | - | - | - | (25 %) | 14 % | 66 % | - |
| EBITDA | - | - | (1.5m) | (1.8m) | (4.0m) | (3.9m) | - |
| % EBITDA margin | - | - | (123 %) | (206 %) | (391 %) | (235 %) | - |
| Profit | - | - | (1.8m) | (2.1m) | (4.2m) | (4.4m) | - |
| % profit margin | - | - | (148 %) | (239 %) | (418 %) | (259 %) | - |
| EV / revenue | - | - | 15.4x | 150.6x | 63.3x | 29.5x | - |
| EV / EBITDA | - | - | -12.5x | -73.1x | -16.2x | -12.6x | - |
| R&D budget | - | - | 1.6m | 1.7m | 2.2m | 2.4m | - |
| R&D % of revenue | - | - | 135 % | 187 % | 214 % | 145 % | - |
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | N/A | IPO | |
* | N/A | $8.0m | Post IPO Debt |
AUD30.0k | Grant | ||
* | AUD3.0m | Grant | |
| Total Funding | CAD2.7m | ||
Related Content
Recent News about Optiscan
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.